4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-22-014951
President & CEO sold 832 shares at $56.10 ($46,675)
- President & CEO acquired 26,041 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Simon, Christopher · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-16 | Sale : show line 1 in the form | −832 | $56.10 | $46,675 | 191,327 | D |
| 2022-05-16 | Grant or award : show line 2 in the form | +26,041 | 217,368 | D | ||
| Open-market sales · 832 sh · avg $56.10 · $46,675 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-05-16 | Grant or award : show line 3 in the form Non-qualified Stock Option (Right to Buy) | +60,891 | 60,891 | D |
Loading xslF345X03/form4.xml…